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The views expressed in rhe Correspondence pub-
lished in rhe Journal are nor necessarily rhose of
rhe Medical Associarion of Sourh Africa.-Editor.
Die menings gelug in die Briewentbriek van die
Tydskrif is nie noodwendig die van die Mediese
Vereniging van Suid-Afrika nie.-Redakteur.
TAY-SACHS DISEASE ADVERTISING
L Van die Redaksie (1973): S. Afr. Med. J., 47, 464.
Nico Coetzee




To the Editor: I am editing a book on renowned and notable
physicians and their faiths. I am interested in hearing from
contributors who have a special knowledge of the faith or
religion of one or more notable and outstanding physicians. I
am considering such physicians as Sir William OsIer and Sir
William Fleming. or those who are still living today.
Would anyone interested in this project, or who could
suggest renowned physicians to write about, please contact me




Aail die Redakteur: Net 'n paar reels om aan te sluit by u
inleidingsartikel' oor pituItere dwergies. Myns insiens moet die
wetgewing wat voorsiening maak vir verwydering van pituiItere
kliere uit kadawers veel wyer wees en oak voorsiening maak
vir benutting van ander liggaamsdele soos byvoorbeeld korneas,
ens.
Ek lees gereeld die briewerubriek en dit val my op dat die
meeste briewe in Engels verskyn-vir die gerief van buite-
landse lesers is dit noodsaaklik-maar dit kom my voor as ek
na die name van die skry\vers self kyk, dat my Afrikaans-





\Ve give full marks to our observant reader. The 'nurse' and 'doctors' were
actors but the patient was genuine and therefore had to be afforded
anonymity.-Editor
To the Editor: There is a most peculiar advertisement on
page XXXIX of the Journal of 17 February 1973. A patient,
with eyes blocked out, is shown with, presumably, consultant,
registrar, houseman and a nurse. If the doctors are genuine,
they are advertlSlng. If not genuine, why block out the
patient's eyes?




To the Editor: May I have the opportunity of replying briefly
to the correspondence'" which resulted from the publication
of my article on Tay-Sachs Disease (TSD).'
My article was written in a simple style, and an attempt
was made to give the reader information on broad principles
only. References were cited for further reading. It is unfor-
tunate that 2 errors in regard to statistics crept into my
article. To correct this fault, the text should have indicated
that there are probably 40000 Jews in the child-bearing age
of whom 1 300 are likely to be carriers.
The figures which Jenkins ei al.' purport to be the likely
incidence of TSD in Johannesburg are fallacious and irrele-
vant. It is scientifically incorrect to use a presumptive figure
of 'approximately 2 cases of TSD per annum' to calculate
the frequency of the disease and to suggest that the frequency
of the disease in South Africa is different from other areas
of the world based upon these calculations.
I consider a limited study of TSD in South Africa to be
both a waste of time and money and that it would serve no
purpose. It is preposterous to presume that 50 % of the
knowledge to be gained is already known and to deduce from
a limited study if whole-population screening is worth while.'
The opinion expressed that psychologic trauma is likely to
result in people tested for a genetic disorder is not true. Dr
Bruno Volk, who incidentally has had much more experience
and has seen more cases of TSD than anyone in the world,
stated: (a) screening the whole Jewish population in South
Africa for TSD would be a very worthwhile project; and
(b) problems suggested as arising from psychologic trauma
should be disregarded as grown-up people should not bury
their heads in the sand in order to avoid the truth.'
It is unfortunate that the laws of nature do not obey the
hypotheses of man. Thus in a family where carrier marries
carrier of a recessively transmitted disease, it is hypothetically
possible that the risk of occurrence of the disease is I in 4.
Of course it may be 1 in 2 in a specific family and the occur-
rence of even I case of such a disease in a family is 100%
occurrence.
While it has been suggested that I case of TSD is likely to
occur per annum in South Africa,' again nature is unpredic-
table. Thus, I believe that at the present time, 5 infants are
languishing with TSD in this country, all of whom will die.
The tragic birth of these infants could have been prevented
and the sooner similar cases are prevented, the better.
Screening programmes should identify every person at risk
and not a selected few.
I. Correspondence (1973): S. Afr. Med. J., 47, 468.
2. Correspondence (1973): Ibid., 47, 597.
3. Van der Horst, R. L. (1973): Ibid., 47, 181.
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COMBINED MEASLES, RUBELLA AND MUMPS
VACCINE
To the Editor: An efficient vaccine is indicated in diseases
which either threaten life or have morbid consequences. This
is particularly so where the disease is inclined to occur in
epidemic form. Smallpox is an ideal indication because of its
high mortality and because it often assumed formidable epi-
demic proportions in the unvaccinated. It is pertinent thal
the applicability of the combined measles, rubella and mumps
vaccine now offered by various firms be critically examined.
Measles carries a considerable morbidity and mortality, par-
ticularly in mal- or undernourished children under 5 years of
age. As in diphtheria and poliomyelitis, the threat from measles
starts at about the age of 6 months when the passive immunity
obtained from the mother disappears. Measles at present
carries a higher mortality than the notifiable infectious diseases
so that immunization is definitely indicated. The best time to
administer measles vaccine is just before 6 months of age-
the same a for triple antigen (diphtheria. pertussis and tetanus)
and poliomyelitis.
Rubella, on the other hand, is never a threat to the life. and
seldom even to the well-being, of the sufferer. Rubella only
acquires its sinister quality when it attacks a woman during
the first 3 months of pregnancy when her child is likely to be
born with physical and mental defects. In addition, even if
such a child is born apparently normal, it continues to ex-
crete rubella vi rus often for the rest of its life, and so con-
stitutes a menace to society. A solution to the problem of
congenital defects so produced, is to ensure that all mothers
of a population are immune to rubella before they start bearing
children, i.e. they should either have suffered from rubella, or
have had efficient immunization from an attenuated live
virus vaccine. It is not safe to use this live virus vaccine later
than 6 weeks before conception, and certainly never during
pregnancy. The solutions are (a) routine rubella immunization
of all 13 - 14-year-old schoolgirls which is offered as a routine
in many advanced countries, and should be considered for
South Africa; (b) before, or even as a condition of. marria~e:
unfortunately this would omit unmarried mothers; (c) married
women at risk. either immediately after childbirth or on con-
dition that efficient contraception is applied; and (d) it has
been reported recently that the Japanese strain of rubella virus
is non-teratogenic. If this should be confirmed and the existing
teratogenic South African virus could be replaced by the
Japanese strain. the problem would likewise be solved.
The administration of rubella vaccine in children under 5
years old appears irrational, as there is no absolute certainty
that the immunity would last until child-bearing age.
Mumps, like rubella, is practically never a threat to thc
sufferer's life. The most important complication is an orchitis
in sexually-mature males, which is very rarely followed by
sterility. The latter is no serious indication for immunization
in this overpopulated world, and whether an orchitis is. is
debatable. However. supposin~ these do indicate immunization.
this should be given to sexually-mature males.
I suggest rubella vaccine should be offered to all 13 - 14-
year-old schoolgirls_ and mumps vaccine concurrently to 13-
14-year-old schoolboys. This would eliminate discrimination
between the sexes in mixed schools.
Thus, a vaccine against measles. rubella and mumps is a
bad combination, although separate vaccines against cach
disease may have a place in prophylaxis.
H. R. Ackermann
Senior Medical Officer




To the Editor: As the Chief Executive of a pharmaceutical
company with extensive international affiliations within a
group which markets a number of psycho-active drugs through-
out the world, I have a professional interest in international
drug abuse patterns. As a father of adolescent children. I hav~
a personal interest.
At a recent congress in London, it was recognized that,
apart from the problems posed by indigenous cannabis in
South Africa, drug abuse in the Republic, and particularly
the misuse of pharmaceutical compounds, was on a scale much
lower than that of some parts of Europe and the USA.
One of the reasons suggested for this was that of relative
communication failure, and the point was made that South
Africa could not hope to escape the consequences of 'im-
proved' communications. Irresponsible reports in the mass
media which draw attention to brand-names. the 'under-
ground' names. availability. how to recognize the product and
the highly subjective effects to be expected can be guaranteed
to stimulate the curiosity of young people.
International travel, particularly that related to the move-
ments of the so-called 'hippies', improves communications even
in the rapidly developing non-print culture of Europe.
So far our lay press has adopted a responsible attitude but
it seems that this is changing. Recently a Transvaal daily
newspaper printed the photograph of a smiling woman holding
a plant of the genus Dafllra. The plant, the seed pod and
seeds were easily identifiable as a common weed throughout
much of South Africa. The accompanying text related the
story of a local youth who swallowed one hundred seeds °for
excitement' and had 'a 4-day hallucinatory trip'. Two days
later, despite an appeal to the journalist concerned not to
identify the product, a Natal Sunday newspaper printed a
story on one of our products, Mandrax, in which, among
other things, it was described as an aphrodisiac.
The symptoms of gross overdosage in selfpoisoning cases
were distorted and linked with its ordinary therapeutic use in
such a way that patients who have taken Mandrax for longer
than 2 months were led to expect convulsions, delirium
tremens, and 'stomach haemorrhage 3 - 5 days after discon-
tinuing'. Attention was also drawn to its abuse potential. This,
together with a photograph of the pack, could be predicted
to have 2 effects. The first is to cause grave concern among
those patients for whom the product has been prescribed and
the second is to draw attention to the fact that psycho-active
drugs taken with alcohol have a potentiating effect.
My local information is that both articles have had the
predicted effect. Adolescents are searching for the 'malpitte'
(mad pips) of Drztura and chewing a few seeds to experiment
with dosage, and some patients, unfortunate enough to have
read and believed the Mandrax article, are concerned for
their lives.
It is doubtful whether any form of control can or should
be exercised over newspapers to preclude this kind of irre-
sponsible reporting. I would suggest, however, that since
presumably journalists have to have recourse to personal
medical advice from time to time, the profession should exert
its not inconsiderable influence over these people, pointing
out the results of irresponsible distortions of medical facts and
the publication of 'do-it-yourself drug abuse formularies.
V. C. Alien
Executive Director
Roussel Laboratories
P.O. Box 39110
Bramley, Tvl
